{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:48:53Z","timestamp":1783108133318,"version":"3.54.6"},"reference-count":143,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.pharmthera.2003.01.001","type":"journal-article","created":{"date-parts":[[2004,3,30]],"date-time":"2004-03-30T05:20:36Z","timestamp":1080624036000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems"],"prefix":"10.1016","volume":"102","author":[{"given":"Caroline A","family":"Kavanagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri A","family":"Rochev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan K","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2003.01.001_BIB1","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1073\/pnas.1031426100","article-title":"Interaction of soft condensed materials with living cells: phenotype\/transcriptome correlations for the hydrophobic effect","volume":"100","author":"Allen","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB2","first-page":"1","article-title":"Controlled release of proteins from 2-hydroxyethyl methacrylate copolymer gels","volume":"21","author":"Antonsen","year":"1993","journal-title":"Biomater Artif Cells Immobil Biotechnol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB3","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/01.CIR.91.11.2793","article-title":"Local delivery of vascular endothelial growth factor accelerates reendothelialisation and attenuates intimal hyperplasia in balloon injured rat carotid artery","volume":"91","author":"Asahara","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.90.1.433","article-title":"Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloons","volume":"90","author":"Azrin","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0008-6363(00)00042-0","article-title":"In vitro evaluation of c7E3-Fab (ReoPro\u2122) eluting polymer-coated coronary stents","volume":"46","author":"Baron","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0163-7258(01)00153-X","article-title":"Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy","volume":"91","author":"Bennett","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0735-1097(95)00277-4","article-title":"The Subcutaneous Heparin and Angioplasty Restenosis Prevention (SHARP) trial. Results of a multicentre randomized trial investigating the effects of high dose unfractionated heparin on angiographic restenosis and clinical outcome","volume":"26","author":"Brack","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0168-3659(95)00134-4","article-title":"Pulsatile local delivery of thrombolytic and antithrombotic agents using poly(N-isopropylacrylamide-co-methacrylic acid) hydrogels","volume":"39","author":"Brazel","year":"1996","journal-title":"J Control Release"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F","article-title":"Influence of biomaterial surface chemistry on the apoptosis of adherent cells","volume":"55","author":"Brodbeck","year":"2001","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB10","doi-asserted-by":"crossref","first-page":"10287","DOI":"10.1073\/pnas.162124199","article-title":"Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo","volume":"99","author":"Brodbeck","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1067\/mlc.2002.121260","article-title":"Interleukin-4 inhibits tumor necrosis factor-alpha-induced and spontaneous apoptosis of biomaterial-adherent macrophages","volume":"139","author":"Brodbeck","year":"2002","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0165-6147(00)01505-4","article-title":"Restenosis: a challenge for pharmacology","volume":"21","author":"Bult","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB13","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1161\/01.CIR.94.7.1553","article-title":"Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study","volume":"94","author":"Cairns","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB14","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1161\/01.CIR.92.9.2463","article-title":"Intracoronary heparin delivery in humans: acute feasibility and long-term results","volume":"92","author":"Camenzind","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB15","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.ATV.20.12.2573","article-title":"Co-administration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization","volume":"20","author":"Chae","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/0741-5214(89)90345-5","article-title":"Efficacy of corticosteroids in suppression of intimal hyperplasia","volume":"10","author":"Chervu","year":"1989","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0169-409X(02)00041-8","article-title":"Targeted drug delivery by thermally responsive polymers","volume":"54","author":"Chilkoti","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/bit.260440120","article-title":"On protein solubility in organic solvents","volume":"44","author":"Chin","year":"1994","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/265625a0","article-title":"Suppression by heparin of smooth muscle cell proliferation in injured arteries","volume":"265","author":"Clowes","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB21","first-page":"208","article-title":"Mechanisms of stenosis after arterial injury","volume":"49","author":"Clowes","year":"1983","journal-title":"Lab Invest"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB19","first-page":"295","article-title":"Kinetics of cellular proliferation after arterial injury: III. Endothelial and smooth muscle growth in chronically denuded vessels","volume":"54","author":"Clowes","year":"1986","journal-title":"Lab Invest"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jbm.1225","article-title":"Adhesion behaviour of monocytes, macrophages and foreign body giant cells on poly(N-isopropylacrylamide) temperature-responsive surfaces","volume":"59","author":"Collier","year":"2001","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB23","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/01.CIR.0000086926.62288.A6","article-title":"Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions","volume":"108","author":"Colombo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB24","first-page":"113","article-title":"The effect of 32P beta-radiotherapy on both vessel remodeling and neointimal hyperplasia after coronary balloon angioplasty and stenting: a three-dimensional intravascular ultrasound investigation","volume":"12","author":"Costa","year":"2000","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB25","first-page":"218","article-title":"Secondary effects of brachytherapy in the treatment of coronary restenosis","volume":"91","author":"Cottin","year":"2001","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB26","first-page":"186A","article-title":"Initial clinical experience of local drug delivery via a porous balloon during percutaneous coronary angioplasty (abstract)","volume":"23","author":"Cumberland","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB27","article-title":"Effect of stent coating alone on in vitro vascular smooth muscle cell proliferation and apoptosis","author":"Curcio","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB28","doi-asserted-by":"crossref","first-page":"118B","DOI":"10.1016\/0735-1097(91)90947-8","article-title":"Low molecular weight heparin (enoxaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit","volume":"17","author":"Currier","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB29","doi-asserted-by":"crossref","first-page":"38A","DOI":"10.1016\/S0735-1097(02)80163-2","article-title":"Incidence of incomplete stent apposition at six-months follow up in the multi centre RAVEL trial","volume":"39","author":"Degertekin","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00019501-199602000-00011","article-title":"Local methylprednisolone inhibition of foreign body response to coated intracoronary stents","volume":"7","author":"De Scheerder","year":"1996","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1357-4310(95)80091-3","article-title":"Polymeric carriers for regional drug therapy","volume":"3","author":"Domb","year":"1995","journal-title":"Mol Med Today"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0168-3659(86)90006-4","article-title":"Thermally reversible hydrogels: III. Immobilization of enzymes for feedback reaction control","volume":"4","author":"Dong","year":"1986","journal-title":"J Control Release"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1054-8807(02)00165-5","article-title":"Poly(N-isopropylacrylamide) co-polymer films as potential vehicles for delivery of an antimitotic agent to vascular smooth muscle cells","volume":"12","author":"Doorty","year":"2003","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB34","first-page":"31","article-title":"Clinical experience with drug eluting stents","volume":"3","author":"Drachman","year":"2002","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0169-409X(96)00480-2","article-title":"Catheter-based drug delivery for restenosis","volume":"24","author":"Eccleston","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB37","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/01.CIR.89.2.770","article-title":"Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis","volume":"89","author":"Edelman","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB38","doi-asserted-by":"crossref","first-page":"4E","DOI":"10.1016\/S0002-9149(98)00189-1","article-title":"Pathobiological responses to stenting","volume":"81","author":"Edelman","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB36","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1073\/pnas.87.10.3773","article-title":"Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury","volume":"87","author":"Edelman","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0378-5173(02)00198-9","article-title":"Evaluation of a new controlled-drug delivery concept based on the use of thermoresponsive polymers","volume":"241","author":"Eeckman","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB40","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/app.1978.070220328","article-title":"Aqueous solutions of poly(N-isopropylacrylamide)","volume":"22","author":"Eliassaf","year":"1987","journal-title":"J Appl Polym Sci"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/01.CIR.100.8.799","article-title":"Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study). The ERASER Investigators","volume":"100","author":"ERASER Investigators","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.CIR.99.1.44","article-title":"Pathology of acute and chronic coronary stenting in humans","volume":"99","author":"Farb","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB43","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1161\/01.CIR.0000019071.72887.BD","article-title":"Morphological predictors of restenosis after coronary stenting in humans","volume":"105","author":"Farb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB44","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/01.CIR.90.2.908","article-title":"Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) Trial","volume":"90","author":"Faxon","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0033-0620(97)80005-9","article-title":"Remodelling of the coronary artery after vascular injury","volume":"40","author":"Faxon","year":"1997","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomised comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators","volume":"331","author":"Fischman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB47","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0037-1613843","article-title":"Inhibition of platelet thrombosis using an activated protein C-loaded stent: in vitro and in vivo results","volume":"83","author":"Foo","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB48","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/0735-1097(94)90658-0","article-title":"Localised intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure augmented diffusion","volume":"23","author":"Fram","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB49","series-title":"Manufacturing and Production Technology","first-page":"333","article-title":"Hydrogels for drug delivery","author":"Gehrke","year":"1990"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0735-1097(91)90735-R","article-title":"Effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolaemic rabbit","volume":"17","author":"Gellman","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0021-9150(01)00618-9","article-title":"Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials","volume":"160","author":"Gershlick","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0735-1097(98)00192-2","article-title":"Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis","volume":"32","author":"Gibson","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.CIR.0000047700.58683.A1","article-title":"TAXUS I: six- and twelve month results from a randomised, double blind trial on a slow releasing paclitaxel-eluting stent for de novo coronary lesions","volume":"107","author":"Grube","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB54","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1016\/S0002-8703(03)00317-X","article-title":"Platelet activation after stenting with heparin-coated versus noncoated stents","volume":"146","author":"Gurbel","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB55","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1067\/mhj.2003.109","article-title":"Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial","volume":"145","author":"Gurbel","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0168-3659(92)90194-V","article-title":"Heparin release from thermosensitive hydrogels","volume":"22","author":"Gutowska","year":"1992","journal-title":"J Control Release"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-3659(97)00041-2","article-title":"Squeezing hydrogels for controlled oral drug delivery","volume":"48","author":"Gutowska","year":"1997","journal-title":"J Control Release"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB58","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.RES.46.5.625","article-title":"Inhibition of rat arterial smooth muscle cell proliferation by heparin: in vivo studies with anticoagulant and nonanticoagulant heparin","volume":"46","author":"Guyton","year":"1980","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB59","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1161\/01.CIR.103.18.2289","article-title":"Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis","volume":"103","author":"Heldman","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB60","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2165\/00003495-199346010-00003","article-title":"Pharmacological approaches to the prevention of restenosis following angioplasty","volume":"46","author":"Herrman","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10601326808051910","article-title":"Solution properties of poly(N-isopropylacrylamide)","volume":"2","author":"Heskins","year":"1968","journal-title":"J Macromol Sci, Chem A"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(01)00239-3","article-title":"Hydrogels for biomedical applications","volume":"43","author":"Hoffman","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB63","first-page":"181","article-title":"A dual-purpose angioplasty\u2014drug infusion catheter for the treatment of intragraft thrombus","volume":"33","author":"Hong","year":"1994","journal-title":"Catheter Cardiovasc Diagn"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB64","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/01.CIR.0000054163.42072.D4","article-title":"Paclitaxel coating reduces in stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT)","volume":"107","author":"Hong","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB65","first-page":"503","article-title":"Optimization of local methylprednisolone delivery to inhibit inflammatory reaction and neointimal hyperplasia of coated coronary stents","volume":"14","author":"Huang","year":"2002","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB66","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1118\/1.1607506","article-title":"Dose model for stent-based delivery of a radioactive compound for the treatment of restenosis in coronary arteries","volume":"30","author":"Janicki","year":"2003","journal-title":"Med Phys"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB67","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.CIR.97.13.1274","article-title":"Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats","volume":"97","author":"Janseens","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB68","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/exmp.2002.2450","article-title":"Tumor necrosis-alpha antibody eluting stents reduce vascular smooth muscle cell proliferation in saphenous vein organ culture","volume":"73","author":"Javed","year":"2002","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0735-1097(92)90119-8","article-title":"Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis","volume":"20","author":"Karas","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB70","first-page":"240","article-title":"Surface expression of ICAM-1 on human endothelial cells grown on potential intra-vascular stent coatings","volume":"56","author":"Kavanagh","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB71","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/heart.83.3.332","article-title":"Outcome from balloon induced coronary artery dissection after intracoronary beta radiation","volume":"83","author":"Kay","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB72","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/01.CIR.103.1.26","article-title":"Local delivery of enoxaparin to decrease restenosis after stenting: results of initial multicentre trial: Polish-American Local Lovenox NIR Assessment study (The POLONIA study)","volume":"103","author":"Kiesz","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB73","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/A:1015887213431","article-title":"Hydrogels: swelling, drug loading and release","volume":"9","author":"Kim","year":"1992","journal-title":"Pharm Res"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB74","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0735-1097(97)00450-6","article-title":"In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia","volume":"31","author":"Kornowski","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-409X(96)00483-8","article-title":"Nanoparticle drug delivery systems for restenosis","volume":"24","author":"Labhasetwar","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB76","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1161\/01.CIR.96.10.3396","article-title":"Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study, Fraxiparine Angioplastie Coronaire Transluminale","volume":"96","author":"Lablanche","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB77","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.2218494","article-title":"New methods of drug delivery","volume":"249","author":"Langer","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB78","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJM200101253440402","article-title":"Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting","volume":"344","author":"Leon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB79","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0735-1097(98)00621-4","article-title":"Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodelling","volume":"33","author":"Le Tourneau","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB80","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0142-9612(01)00297-6","article-title":"Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation","volume":"23","author":"Lewis","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB81","first-page":"47","article-title":"A cascade model of restenosis. A special case of atherosclerosis progression","volume":"86","author":"Libby","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB82","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1161\/01.CIR.90.4.2070","article-title":"Local drug delivery for the prevention of restenosis. Fact, Fancy and future","volume":"90","author":"Lincoff","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB83","first-page":"172","article-title":"Study of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): a first-in-human multicenter pilot trial","volume":"60","author":"Liu","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB84","first-page":"193","article-title":"Treatment of intracoronary thrombus with urokinase infusion using a new, site-specific drug delivery system: the Dispatch catheter","volume":"32","author":"McKay","year":"1994","journal-title":"Catheter Cardiovasc Diagn"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB85","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1050-1738(97)00066-2","article-title":"Novel stents for the prevention of restenosis","volume":"7","author":"McKenna","year":"1997","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB86","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1053\/euhj.1999.2041","article-title":"Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS Trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study","volume":"21","author":"Meneveau","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB89","first-page":"149","article-title":"Treatment of acute stent thrombosis with local urokinase therapy using catheter based, drug delivery systems: a case report","volume":"34","author":"Mitchel","year":"1995","journal-title":"Catheter Cardiovasc Diagn"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB87","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/01.CIR.90.4.1979","article-title":"Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons","volume":"90","author":"Mitchel","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB88","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.91.3.785","article-title":"Enhanced intracoronary thrombolysis with urokinase using a novel, local drug delivery system: in vitro, in vivo, and clinical studies","volume":"91","author":"Mitchel","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB90","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomised comparison of a sirolimus-eluting stent with a standard stent for coronary revascularisation","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB91","article-title":"SIRIUS: a US multicentre, randomised, double-blind study of the sirolimus stent in de novo lesions","author":"Moses","year":"2002"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB92","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB93","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/BF02618093","article-title":"A microsustained release system for epidermal growth factor","volume":"19","author":"Murray","year":"1983","journal-title":"In Vitro"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB94","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1522-1865(03)00143-4","article-title":"Fabrication of drug-eluting covered stents with micropores and differential coating of heparin and FK506","volume":"4","author":"Nakayama","year":"2003","journal-title":"Cardiovasc Radiat Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB95","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/0735-1097(94)90659-9","article-title":"Local delivery of a synthetic antithrombin with a hydrogel coated angioplasty balloon catheter inhibits platelet dependent thrombosis","volume":"23","author":"Nunes","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB96","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1161\/01.CIR.92.7.1697","article-title":"Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel coated balloon","volume":"92","author":"Nunes","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB97","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0142-9612(95)93257-E","article-title":"Mechanism of cell detachment from temperature-modulated, hydrophilic-hydrophobic polymer surfaces","volume":"116","author":"Okano","year":"1995","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB98","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(00)00058-2","article-title":"Endothelial cell delivery for cardiovascular therapy","volume":"42","author":"Parikh","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB99","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.2526370","article-title":"Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury","volume":"245","author":"Powell","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/3-540-45725-9_35","article-title":"Surface modification for controlled cell growth on copolymers of N-isopropylacrylamide","volume":"118","author":"Rochev","year":"2001","journal-title":"Prog Colloid Polym Sci"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB101","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1161\/01.CIR.91.12.2995","article-title":"Endovascular stent design dictates experimental restenosis and thrombosis","volume":"91","author":"Rodgers","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB102","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0142-9612(93)90230-Y","article-title":"Preliminary report on cell culture on a thermally reversible copolymer","volume":"13","author":"Rollason","year":"1993","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB103","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1161\/01.CIR.101.21.2467","article-title":"Geographic miss cause of treatment failure in radio-oncology applied to intracoronary radiation therapy","volume":"101","author":"Sabate","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB104","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.CIR.84.1.232","article-title":"Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits","volume":"84","author":"Sarembock","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB105","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/277665a0","article-title":"Promotion of microtubule assembly in vitro by taxol","volume":"277","author":"Schiff","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB106","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0079-6700(92)90023-R","article-title":"Poly(N-isopropylacrylamide): experiment, theory and application","volume":"17","author":"Schild","year":"1992","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB107","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1021\/j100373a088","article-title":"Microcalorimetric detection of lower critical solution temperatures in aqueous polymer solutions","volume":"94","author":"Schild","year":"1990","journal-title":"J Phys Chem"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB108","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(03)14462-5","article-title":"Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)","volume":"362","author":"Schofer","year":"2003","journal-title":"Lancet"},{"issue":"7A","key":"10.1016\/j.pharmthera.2003.01.001_BIB109","doi-asserted-by":"crossref","first-page":"14E","DOI":"10.1016\/S0002-9149(98)00191-X","article-title":"Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and\/or remodelling","volume":"81","author":"Schwartz","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB110","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJM198806303182603","article-title":"Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty","volume":"318","author":"Schwartz","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB111","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0735-1097(92)90389-5","article-title":"The restenosis paradigm revisited: an alternative proposal for cellular mechanisms","volume":"20","author":"Schwartz","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB112","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/01.CIR.84.4.1568","volume":"84","author":"Serruys","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB113","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease","volume":"331","author":"Serruys","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB114","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199509213331203","article-title":"A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. The HELVETICA trial","volume":"333","author":"Serruys","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/euhj.1998.1150","article-title":"A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty. Final results of the Fluvastatin Angiographic Restenosis (FLARE) trial","volume":"20","author":"Serruys","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB116","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/01.CIR.0000025585.63486.59","article-title":"Intravascular ultrasound findings in the multicentred, randomised, double-blind RAVEL (Randomised study with the sirolimus-eluting Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial","volume":"106","author":"Serruys","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB117","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1072-7515(98)00163-X","article-title":"Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo","volume":"187","author":"Shears","year":"1998","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB118","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","article-title":"Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty","volume":"316","author":"Sigwart","year":"1987","journal-title":"N Engl Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB119","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/01.ATV.17.3.528","article-title":"7E3 monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa cross reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1","volume":"17","author":"Simon","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/359067a0","article-title":"Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo","volume":"359","author":"Simons","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB121","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1172\/JCI117240","article-title":"Antisense proliferating cell nuclear antigen oligonucleotides inhibit hyperplasia in a rat carotid artery injury model","volume":"93","author":"Simons","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB122","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/01.CIR.0000051720.59095.6D","article-title":"Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries","volume":"107","author":"Sousa","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB123","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/hc3601.093987","article-title":"Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model","volume":"104","author":"Suzuki","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB124","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0008-6363(96)00188-5","article-title":"The Dispatch catheter as a delivery tool for arterial gene transfer","volume":"33","author":"Tahlil","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0735-1097(98)00551-8","article-title":"Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACCT-II Investigators. Integrelin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II","volume":"33","author":"Tardiff","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB126","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/01.CIR.101.4.360","article-title":"Three year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial","volume":"101","author":"Teirstein","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB127","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0142-9612(99)00260-4","article-title":"Temperature-dependent modulation of blood platelet movement and morphology on poly(N-isopropylacrylamide)-grafted surfaces","volume":"21","author":"Uchida","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB128","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/bit.1086","article-title":"Engineering temperature-sensitive poly(N-isopropylacrylamide) polymers as carriers of therapeutic proteins","volume":"73","author":"Uludag","year":"2001","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.CIR.95.2.438","article-title":"Stent endothelialisation: time course, impact of local catheter delivery, feasibility of recombinant protein administration and response to cytokine expedition","volume":"95","author":"Van Belle","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB129","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0735-1097(97)00049-1","article-title":"Passivation of metallic stents following arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening","volume":"29","author":"Van Belle","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB131","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM200101253440401","article-title":"Endoluminal beta-radiation therapy for the prevention of coronary-restenosis after balloon angioplasty. The Dose-Finding Study Group","volume":"344","author":"Verin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB132","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0735-1097(02)02562-7","article-title":"Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS Study)","volume":"40","author":"Versaci","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB133","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI117078","article-title":"Local delivery of dexamethasone for the prevention of neointimal proliferation in a rat model of balloon angioplasty","volume":"93","author":"Villa","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB134","first-page":"163","article-title":"Comparative pathology: radiation induced coronary artery disease in man and animals","volume":"3","author":"Viramani","year":"1998","journal-title":"Semin Interv Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(98)00042-X","article-title":"Growth factor release from thermally reversible tissue culture substrates","volume":"55","author":"Von Recum","year":"1997","journal-title":"J Control Release"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB136","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/01.CIR.91.5.1533","article-title":"Endovascular low dose irradiation inhibits neointima formation after coronary artery balloon injury in swine: a possible role for radiation therapy in restenosis prevention","volume":"91","author":"Waksman","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB137","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/0735-1097(95)00010-2","article-title":"Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in swine. Persistent benefit at 6-month follow-up","volume":"25","author":"Wiedermann","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/13543784.12.5.771","article-title":"Therapeutic potential of active stent coating","volume":"12","author":"Wieneke","year":"2003","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB139","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0360-3016(96)00299-4","article-title":"The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation","volume":"36","author":"Wilcox","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB140","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jbm.a.10137","article-title":"Extended delivery of the antimitotic agent colchicine from thermoresponsive N-isopropylacrylamide-based copolymer films to human vascular smooth muscle cells","volume":"67A","author":"Wilson","year":"2003","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB141","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/marc.1990.030111109","article-title":"Thermo-responsive polymeric surfaces: control of attachment and detachment of cultured cells","volume":"11","author":"Yamada","year":"1990","journal-title":"Makromol Chem Rapid Commun"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB142","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1163\/156856291X00250","article-title":"Surface-modulated skin layers of thermal responsive hydrogels as on-off switches: I Drug release","volume":"3","author":"Yoshida","year":"1991","journal-title":"J Biomater Sci Polym Ed"},{"key":"10.1016\/j.pharmthera.2003.01.001_BIB143","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-3659(01)00266-8","article-title":"Covalently conjugated VEGF-fibrin matrices for endothelialization","volume":"72","author":"Zisch","year":"2001","journal-title":"J Control Release"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725804000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725804000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:47:53Z","timestamp":1759009673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725804000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":143,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0163725804000099"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2003.01.001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2003.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}